SARS-CoV-2 and the clinical features of COVID-19 dramatically highlight the need to better understand why some patients are so strikingly more susceptible to a viral respiratory pathogen. Several researchers involved in RESIST are successfully working to solve this challenge. They are seeking new diagnostic methods, improving vaccines and cloning broadly neutralising monoclonal antibodies.
On this page, we have bundled publications on research related to SARS-CoV-2, as well as news related to the topic of corona infections. It also contains videos and press releases explaining the research, as well as questions and their answers about the topic. We will be happy to keep you up to date.